Sumatriptan: Known uses and market status in India
Summary
The TxGNN model’s candidates for Sumatriptan are all known uses, so there is currently no new predicted indication. The one candidate that can be traced to a source is already supported by a licence in another country. This page lists it for reference only.
Quick overview
Item
Content
New predicted indications
None (all traceable model candidates are known uses)
Known uses among model candidates
1
Evidence level
Not applicable
India Market Status
Listed in a compiled Indian medicine price dataset (at least 20) – CDSCO approval status is not included in this data
Number of Listed Products
at least 20
Known uses among the model’s candidates
Approved (supported by a licence or label)
Indication
Source
migraine with brainstem aura
licence in another country (approved indication: migraine)
Related to an approved indication (same disease category)
Indication
Approved category
none
none
Relations recorded in the knowledge graph (no approval found)
Indication
none
India Market Information
Licence
Product
Dosage form
Status
202596
Sumitrex 6mg Injection
vial of 1 ml Injection
Valid
204762
Sumitop 25 Tablet
strip of 10 tablets
Valid
152094
Naprowel S 85mg/500mg Tablet
strip of 2 tablets
Valid
201133
Somatran N 85mg/500mg Tablet
strip of 4 tablets
Valid
202285
Sumalgia 85mg/500mg Tablet
strip of 4 tablets
Valid
152133
Naprosuma Tablet
strip of 2 tablets
Valid
202940
Sumitop 50 Tablet
strip of 10 tablets
Valid
201060
Sumitrex 50mg Tablet
strip of 1 Tablet
Valid
85481
Fyn-Head Tablet
strip of 4 tablets
Valid
217954
Throbexit Tablet
strip of 4 tablets
Valid
200991
Suminat 100 Tablet
strip of 1 Tablet
Valid
205859
Sumisun 25mg Tablet
strip of 10 tablets
Valid
205577
Sumatan 25mg Tablet
strip of 10 tablets
Valid
103663
Headset Tablet
strip of 2 tablets
Valid
202585
Suminat Fast 25mg Tablet
strip of 1 Tablet
Valid
207941
Sumatan 100mg Tablet
strip of 10 tablets
Valid
202622
Sumitrex 25mg Tablet
strip of 1 Tablet
Valid
151207
Napros 85mg/500mg Tablet
strip of 10 tablets
Valid
199927
Suminat 25 Tablet
strip of 1 Tablet
Valid
203752
Sumitrex 100mg Tablet
strip of 1 Tablet
Valid
Only part of the licence list is held in the data; the list may be incomplete.
Safety Considerations
Contraindications (from the knowledge graph, not label text): The TxGNN knowledge graph links sumatriptan to contraindications in the following groups. These need to be confirmed against the package insert.
Cardiovascular: hypertension, coronary artery disease, myocardial infarction, congestive heart failure, peripheral vascular disease, and other heart disease
Cerebrovascular: stroke, cerebral infarction, and other cerebrovascular disorders
Hepatic and renal: liver failure, liver disease, and kidney disease
Other: epilepsy, diabetes mellitus, diabetic ketoacidosis, substance abuse or dependence, blood coagulation disease, obesity, hemoglobinopathy, and anaemia
Drug Interactions: 114 interactions are recorded. Major-level interactions include:
Serotonergic or appetite-suppressant agents: dexfenfluramine, fenfluramine, lorcaserin, sibutramine
Moderate-level interactions include morphine and liposomal morphine.
Subtype-specific caution: Triptans have historically carried caution labelling for basilar-type and hemiplegic migraine because of theoretical vasoconstriction risk.
Package insert warnings and contraindications were not available for this report. Please refer to the package insert for full safety information.
Disclaimer
This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.